Sofinnova Partners closes oversubscribed €82 million MD Start IV fund to build new MedTech startups
Paris-based Sofinnova Partners closed its oversubscribed €82M MD Start IV fund, continuing a strategy since 2008 to build new medtech companies from scratch. This gives European medtech founders another dedicated company-building vehicle to approach for early capital.